Journals / Türk Geriatri Dergisi / 2016 / Cilt: 19 - Sayı: 3

PRİMER TÜMÖR REZEKSİYONU YAŞLI METASTATİK GASTRİK KANSERLİ HASTALARDA SAĞKALIMI ETKİLER Mİ?

DOES PRIMARY TUMOR RESECTION AFFECT SURVIVAL IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER? ABSTRACT

Pages
169–173
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When we evaluated the overall survival (OS) of the groups, the median OS was significantly higher in the PTR (+) group (11.5 months, 95% CI 8.4-14.6) than in the PTR (-) group(7.2 months, 95% CI 4.3-10.0) (p=0.001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: In this study, the effect of primary tumor resection (PTR) on the survival ofpatients with metastatic gastric carcinoma (mCG) aged over 65 years was aimed to be searched.
📊
Key Findings & Data:Materials and Method: In total, 98 patients with mCG from the Akdeniz University,Necmettin Erbakan University, and Antalya Training and Research Hospital databases who wereaged over 65 years were retrospectively evaluated.
💡
Conclusion & Impact:When we evaluated the overall survival (OS) of the groups, the median OS was significantly higher in the PTR (+) group (11.5 months, 95% CI 8.4-14.6) than in the PTR (-) group(7.2 months, 95% CI 4.3-10.0) (p=0.001).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: In this study, the effect of primary tumor resection (PTR) on the survival ofpatients with metastatic gastric carcinoma (mCG) aged over 65 years was aimed to be searched. Materials and Method: In total, 98 patients with mCG from the Akdeniz University,Necmettin Erbakan University, and Antalya Training and Research Hospital databases who wereaged over 65 years were retrospectively evaluated. The patients were divided into two groupsbased on PTR: PTR (+) and PTR (-).Results: The median progression-free survival in the PTR (+) group was 10.2 months (95%confidence interval [CI] 6.6-13.7) and in the PTR (-) group was 5.9 months (95% CI 2.6-9.3)(p=0.054). When we evaluated the overall survival (OS) of the groups, the median OS was significantly higher in the PTR (+) group (11.5 months, 95% CI 8.4-14.6) than in the PTR (-) group(7.2 months, 95% CI 4.3-10.0) (p=0.001). In the final multivariate analysis, none of the parameters studied were independent prognostic factors. Conclusion: PTR may be beneficial for the survival of patients with mGC aged over 65 years.

Özet

Giriş: Bu araştırmada 65 yaş üstü metastatik gastrik kanserli (mGK) hastalarda tanıda primer tümör rezeksiyonunun (PTR) sağ kalıma etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Altmış beş yaş üstü mGK'lı 98 hasta verisi Akdeniz Üniversitesi, Necmettin Erbakan Üniversitesi ve Antalya Eğitim ve Araştırma Hastanesi veritabanlarından retrospektif olarak incelendi. Hastalar PTR'ye göre PTR (+) ve PTR (-) olarak iki gruba ayrıldı. Bulgular: PTR (+) grupta medyan progresyonsuz sağkalım 10.2 [95% CI 6.6-13.7] ay iken, PTR (-) grupta 5.9 [95% CI 2.6-9.3] aydı (p=0.054). Genel sağkalım açısından incelendiğinde PTR (+) grubun sağkalım süresi anlamlı olarak daha yüksek bulundu (p=0.001). PTR (+) grubun sağkalımı 11.5 [95% CI 8.4-14.6] ay iken, PTR (-) grubun sağkalımı 7.2 [95% CI 4.3-10.0] aydı. Çok değişkenli analizde hiç bir parametre bağımsız prognostik faktör olarak bulunamadı. Sonuç: Altmış beş yaş üstü tanıda MGC hastalarda primer tümörün cerrahisinin sağ kalıma faydası olabilir.

🔖

Cite This Article

KARAAĞAÇ, M., ERYILMAZ, M. K., GÖKSU, S. S., SALİM, D. K., COŞKUN, H. Ş., GÜNDÜZ, Ş., TAZEGÜL, G., MÜSRİ, F. Y., MÜSRİ, Ö. C., MUTLU, H. (2022). PRİMER TÜMÖR REZEKSİYONU YAŞLI METASTATİK GASTRİK KANSERLİ HASTALARDA SAĞKALIMI ETKİLER Mİ?. Türk Geriatri Dergisi, Cilt: 19 - Sayı: 3, 169–173. https://ajindex.com/articles/623793

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010
  2. 46(6):1101-10. (PMID:20219351). Chang YR, Han DS, Kong SH, et al. The value of palliative gastrectomy in gastric cancer with distant metastasis. Ann Surg Oncol 2012
  3. 19(4):1231-9. (PMID:22045464). Bajwa A, Blunt N, Vyas S, et al. Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. Eur J Surg Oncol 2009
  4. 35(2):164-7. (PMID:18644695). Heng DY, Wells JC, Rini BI, et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2014
  5. 66(4):704-10. (PMID:24931622). Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH. Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg 2011
  6. 98(11):1566-72. (PMID:21858791). Zhang JZ, Lu HS, Huang CM, et al. Outcome of palliative total gastrectomy for stage IV proximal gastric cancer. Am J Surg 2011l
  7. 202(1):91-6. (PMID:21600557). Ouchi K, Sugawara T, Ono H, et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998
  8. 69(1):41-4. (PMID:9762890). Isozaki H, Okajima K, Kawashima Y, et al. Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol 1993
  9. 53(4):247-51. (PMID:8341056). Maekawa S, Saku M, Maehara Y, et al. Surgical treatment for advanced gastric cancer. Hepatogastroenterology. 1996
  10. 43(7):178-86. (PMID:8682459). Thompson GB, van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet. 1993 Sep 18
  11. 342(8873):713-8. (PMID:8103825). Amini A, Sanati H. Complete pathologic response with combi- nation oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer. Anticancer Drugs 2011
  12. 22(10):1024-6. (PMID:21822120). Kranenbarg EK, van de Velde CJ. Gastric cancer in the elderly. Eur J Surg Oncol 1998
  13. 24(5):384-90. (PMID:9800965). Dittmar Y, Rauchfuss F, Goetz M, et al. Non-curative gastric resection for patients with stage 4 gastric cancer-a single center experience and current review of literature. Langenbecks Arch Surg 2012
  14. 397(5):745-53. (PMID:22307547). Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric canc